Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin J McPhillie

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Pharmaceuticals (Basel, Switzerland)|June 1, 2023
Developments in Non-Intercalating Bacterial Topoisomerase Inhibitors: Allosteric and ATPase Inhibitors of DNA Gyrase and Topoisomerase IVScott Grossman, Colin W G Fishwick, Martin J McPhillie
Future Medicinal Chemistry|October 4, 2021
Exploitation of a novel allosteric binding region in DNA gyrase and its implications for antibacterial drug discoveryKyle M Orritt, Anthony Maxwell, Colin Wg Fishwick, et al.
Current Topics in Medicinal Chemistry|August 18, 2016
New Opportunities in the Structure-based Design of Anti-Protozoan AgentsJames A Gordon, Colin W G Fishwick, Martin J McPhillie
Parasitology|June 18, 2013
An in silico structure-based approach to anti-infective drug discoveryFraser Cunningham, Martin J McPhillie, A Peter Johnson, et al.
European Journal of Medicinal Chemistry|March 18, 2019
N-Cinnamoylanthranilates as human TRPA1 modulators: Structure-activity relationships and channel binding sitesArundhasa Chandrabalan, Martin J McPhillie, Alyn H Morice, et al.
Chemical Biology & Drug Design|July 1, 2014
Computational methods to identify new antibacterial targetsMartin J McPhillie, Ricky M Cain, Sarah Narramore, et al.
The Journal of General Virology|December 1, 2025
Discovery of three small-molecule inhibitors targeting <i>Ebolavirus</i> genome replication and transcriptionVictoria Easton, Martin J McPhillie, John Barr, et al.
RSC Medicinal Chemistry|June 1, 2022
Recent developments in the structural characterisation of the IR and IGF1R: implications for the design of IR-IGF1R hybrid receptor modulatorsSamuel J Turvey, Martin J McPhillie, Mark T Kearney, et al.
Bioorganic & Medicinal Chemistry|January 16, 2022
Discovery of a benzimidazole-based dual FLT3/TrKA inhibitor targeting acute myeloid leukemiaEman M E Dokla, Amal Kamal Abdel-Aziz, Sandra N Milik, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Structure-based ligand design of novel bacterial RNA polymerase inhibitorsMartin J McPhillie, Rachel Trowbridge, Katherine R Mariner, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Pharmaceuticals (Basel, Switzerland)|June 1, 2023
Developments in Non-Intercalating Bacterial Topoisomerase Inhibitors: Allosteric and ATPase Inhibitors of DNA Gyrase and Topoisomerase IVScott Grossman, Colin W G Fishwick, Martin J McPhillie
Future Medicinal Chemistry|October 4, 2021
Exploitation of a novel allosteric binding region in DNA gyrase and its implications for antibacterial drug discoveryKyle M Orritt, Anthony Maxwell, Colin Wg Fishwick, et al.
Current Topics in Medicinal Chemistry|August 18, 2016
New Opportunities in the Structure-based Design of Anti-Protozoan AgentsJames A Gordon, Colin W G Fishwick, Martin J McPhillie
Parasitology|June 18, 2013
An in silico structure-based approach to anti-infective drug discoveryFraser Cunningham, Martin J McPhillie, A Peter Johnson, et al.
European Journal of Medicinal Chemistry|March 18, 2019
N-Cinnamoylanthranilates as human TRPA1 modulators: Structure-activity relationships and channel binding sitesArundhasa Chandrabalan, Martin J McPhillie, Alyn H Morice, et al.
Chemical Biology & Drug Design|July 1, 2014
Computational methods to identify new antibacterial targetsMartin J McPhillie, Ricky M Cain, Sarah Narramore, et al.
The Journal of General Virology|December 1, 2025
Discovery of three small-molecule inhibitors targeting <i>Ebolavirus</i> genome replication and transcriptionVictoria Easton, Martin J McPhillie, John Barr, et al.
RSC Medicinal Chemistry|June 1, 2022
Recent developments in the structural characterisation of the IR and IGF1R: implications for the design of IR-IGF1R hybrid receptor modulatorsSamuel J Turvey, Martin J McPhillie, Mark T Kearney, et al.
Bioorganic & Medicinal Chemistry|January 16, 2022
Discovery of a benzimidazole-based dual FLT3/TrKA inhibitor targeting acute myeloid leukemiaEman M E Dokla, Amal Kamal Abdel-Aziz, Sandra N Milik, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Structure-based ligand design of novel bacterial RNA polymerase inhibitorsMartin J McPhillie, Rachel Trowbridge, Katherine R Mariner, et al.
Pageof 3